431 related articles for article (PubMed ID: 8207673)
1. Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamides.
Schmidt DE; Votaw JR; Kessler RM; de Paulis T
J Pharm Sci; 1994 Mar; 83(3):305-15. PubMed ID: 8207673
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
Mukherjee J; Yang ZY; Das MK; Brown T
Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
[TBL] [Abstract][Full Text] [Related]
3. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
[TBL] [Abstract][Full Text] [Related]
4. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.
de Paulis T; Kumar Y; Johansson L; Rämsby S; Florvall L; Hall H; Angeby-Möller K; Ogren SO
J Med Chem; 1985 Sep; 28(9):1263-9. PubMed ID: 4040977
[TBL] [Abstract][Full Text] [Related]
5. Influence of substituents in fluorobenzene derivatives on the cytochrome P450-catalyzed hydroxylation at the adjacent ortho aromatic carbon center.
Koerts J; Velraeds MM; Soffers AE; Vervoort J; Rietjens IM
Chem Res Toxicol; 1997 Mar; 10(3):279-88. PubMed ID: 9084907
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamide drug models.
Clark CR; Garcia-Roura LE
J Chromatogr Sci; 1989 Mar; 27(3):111-7. PubMed ID: 2708496
[TBL] [Abstract][Full Text] [Related]
7. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
[TBL] [Abstract][Full Text] [Related]
8. Impact of Fluoroalkyl Substituents on the Physicochemical Properties of Saturated Heterocyclic Amines.
Melnykov KP; Tavlui O; Skreminskiy A; Kuchkovska YO; Grygorenko OO
Chemistry; 2022 Oct; 28(55):e202201601. PubMed ID: 35699162
[TBL] [Abstract][Full Text] [Related]
9. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships of salicylamide neuroleptic agents.
Gupta SP; Saha RN; Singh P
Drug Des Deliv; 1990 May; 6(1):41-7. PubMed ID: 1981828
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Chumpradit S; Kung MP; Billings J; Mach R; Kung HF
J Med Chem; 1993 Jan; 36(2):221-8. PubMed ID: 8093734
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
[TBL] [Abstract][Full Text] [Related]
14. Molecular and crystal structure of the hydrochloride monohydrate of (R)-N-[[1-(4-fluorobenzyl)-2-pyrrolidinyl]methyl]-5-bromo-2,3- dimethoxybenzamide, NCQ 115, a novel dopamine D2 receptor antagonist.
Csöregh I; Högberg T
Acta Pharm Nord; 1992; 4(1):1-4. PubMed ID: 1387534
[TBL] [Abstract][Full Text] [Related]
15. Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives.
Estour F; Ferranti V; Chabenat C; Toussaint E; Galons H; Lafont O
J Pharm Biomed Anal; 2007 Oct; 45(2):237-42. PubMed ID: 17656059
[TBL] [Abstract][Full Text] [Related]
16. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride.
Clark CR; Smith FT; Clark MR; Garcia-Roura LE
J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
[TBL] [Abstract][Full Text] [Related]
19. Octanol/water partition coefficient of ortho-substituted aromatic solutes.
Sotomatsu T; Shigemura M; Murata Y; Fujita T
J Pharm Sci; 1993 Aug; 82(8):776-81. PubMed ID: 8377112
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation.
Sabbioni G
Chem Biol Interact; 1992 Jan; 81(1-2):91-117. PubMed ID: 1730150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
